Terazosin 62135-0460
Product NDC
62135-0460- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 30, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA075614
Need to source Terazosin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Terazosin Hydrochloride | 5 mg/1 |
Drug Class
Adrenergic alpha-Antagonists [MoA]alpha-Adrenergic Blocker [EPC]
Packaging Options(1)
90 CAPSULE in 1 BOTTLE (62135-460-90)